Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bio-molecular effects of interferon-beta and vitamin D association in multiple sclerosis
2010-023677-19Phase 2Active
- Sponsor
- San Luigi Gonzaga Hospital
- Start
- Jun 2011
- Modality
- Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of interferon beta-1b and cholecalciferol in multiple sclerosis (MS) and secondary-progressive multiple sclerosis (SPMS), sponsored by San Luigi Gonzaga Hospital. Primary endpoints: Biomolecular effects of interferon beta-1b and vitamin D association and Incidence of neutralizing and binding antibodies to interferon beta. Started Jun 2011; status: active.
02
Drugs
interferon beta-1bcholecalciferol
03
Conditions
multiple sclerosis (MS)secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on 2010-023677-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023677-19.